Pulmonic Valve Regurgitation: Evaluation and Management
For symptomatic patients with moderate or greater pulmonary regurgitation (PR) and RV dilation or dysfunction, pulmonary valve replacement is recommended. 1
Evaluation
Initial Assessment
Transthoracic echocardiography (TTE) is the primary diagnostic tool for evaluating PR severity, RV size and function, and associated lesions 1. Key parameters to assess include:
- Vena contracta width: ≥0.7 cm indicates severe PR 2
- Color Doppler jet characteristics: Large central jets suggest severity
- RV dimensions and function: Progressive RV dilation is a critical marker
- Pulmonary artery pressure: Elevated pressures worsen regurgitation 3
Advanced Imaging
Cardiac MRI has become essential for quantifying PR severity and RV volumes, particularly in post-tetralogy of Fallot patients 3, 4. Critical thresholds include:
- Regurgitant fraction >40-50%
- RV end-diastolic volume >150 mL/m² (normal 75 mL/m²)
- RV ejection fraction <0.40
QRS duration >180 ms on ECG correlates with RV size and predicts malignant ventricular arrhythmias and sudden death 3, 4.
Clinical Context
Mild PR
- Common finding: May be normal on Doppler echocardiography 3
- Management: Interval follow-up only 1
- Prognosis: Generally benign with rare progression
Post-Surgical PR
The most common scenario is PR following repair of pulmonary stenosis or tetralogy of Fallot 1, 3. While 87% of patients develop PR after valvotomy, RV systolic dysfunction occurs in only 9% initially 3. However, long-standing severe PR leads to:
- Progressive RV dilation and dysfunction
- Exercise intolerance
- Ventricular arrhythmias
- Heart failure
- Increased risk of sudden death 3, 4
Management Algorithm
For Symptomatic Patients (NYHA Class II-IV)
Pulmonary valve replacement is indicated (Class I) when moderate or greater PR is present with RV dilation or dysfunction 1. Symptoms include:
- Dyspnea
- Chest pain
- Exercise intolerance referable to PR
For Asymptomatic Patients
The decision is more nuanced and requires serial assessment 1:
- Perform cardiopulmonary exercise testing (CPET) and advanced imaging
- Intervene (Class IIb) if any of the following develop:
- Progressive RV dilation
- Progressive RV dysfunction
- Progressive decrease in exercise capacity
- QRS duration >180 ms 3
Critical Pitfall
Do not wait until RV function deteriorates irreversibly 3. Similar to aortic regurgitation, intervention should be considered before permanent ventricular damage occurs. The exact thresholds remain debated, but most experts favor intervention before severe RV dysfunction develops.
Intervention Options
Surgical Valve Replacement
Pulmonary valve replacement with homograft or xenograft is performed with low operative risk 3, 4. Benefits include:
- Reduction in regurgitant fraction
- Decrease in RV end-diastolic volumes
- Stabilization of QRS duration
- Decreased incidence of atrial and ventricular tachyarrhythmias (when combined with cryoablation) 3
Important limitation: RV ejection fraction shows little improvement post-operatively 3, 4, reinforcing the need for timely intervention.
Transcatheter Options
Transcatheter pulmonary valve replacement (tPVR) is FDA-approved for failing surgical conduits or bioprosthetic valves 5, 6. The Melody valve® (2010) and Sapien XT valve® (2016) offer less invasive alternatives with short and mid-term results equivalent to surgery 6.
Surveillance Strategy
For moderate or greater PR with RV enlargement but no symptoms:
- Imaging and CPET at regular intervals
- Monitor for progressive RV dilation, dysfunction, or declining exercise capacity
- Consider intervention when objective deterioration occurs 1
Key consideration: Significant PR causes RV dilation. If moderate or greater PR exists with normal RV size, either the PR severity is overestimated or restrictive RV physiology is present, warranting further investigation 1.
Special Populations
Post-Tetralogy of Fallot Repair
This population requires lifelong surveillance 6. Many develop regurgitant fractions exceeding 40-50% with marked RV dilation 3, 4. The 2018 AHA/ACC guidelines specifically address this high-risk group with detailed algorithms 1.
Congenital/Idiopathic PR
Rare as isolated lesion, occasionally seen with idiopathic pulmonary artery dilation or connective tissue disorders 3. Management follows the same principles based on severity and RV consequences.